BIOCON BIOLOGICS UK PLC
Get an alert when BIOCON BIOLOGICS UK PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£9.4k
USD 12,372
+54% vs 2025
Net assets
£1m
USD 1,384,122
-4.5% lowest in 3 filed years
Employees
10
+25% vs 2025
Profit before tax
-£31k
USD -40,808
+6.4% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Net assets
3-year trend · vs Basic Materials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £416,327,581 | £375,116 | £442,247 | +17.9% | |
| Operating profit | -£60,065,706 | £8,254 | £29,149 | +253.1% | |
| Profit before tax | -£26,907,853 | -£32,958 | -£30,857 | +6.4% | |
| Net profit | -£11,800,982 | -£25,814 | -£24,498 | +5.1% | |
| Cash | £2,452,502 | £6,074 | £9,355 | +54% | |
| Total assets less current liabilities | £1,821,031,507 | £1,952,901 | £1,866,815 | -4.4% | |
| Net assets | £1,080,957,093 | £1,096,222 | £1,046,595 | -4.5% | |
| Equity | £1,080,957,093 | £1,096,222 | £1,046,595 | -4.5% | |
| Average employees | — | 8 | 10 | +25% | |
| Wages | £379,196 | £1,444 | £2,080 | +44% | |
| Directors' remuneration | £224,826 | £197 | £284 | +44.2% |
Figures converted to GBP from USD at 0.756 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Operating margin | -14.4% | 2.2% | 6.6% | |
| Net margin | -2.8% | -6.9% | -5.5% | |
| Return on capital employed | -3.3% | 0.4% | 1.6% | |
| Gearing (liabilities / total assets) | 49.5% | 47.7% | 49.3% | |
| Current ratio | 0.78x | 1.46x | 1.30x | |
| Interest cover | -0.97x | 0.14x | 0.48x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- BIOCON BIOLOGICS UK PLC 2025-10-29 → present
- BIOCON BIOLOGICS UK LIMITED 2025-10-21 → 2025-10-29
- BIOSIMILARS NEWCO LIMITED 2022-07-27 → 2025-10-21
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KNAV Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going-concern basis which the directors consider to be appropriate for the following reasons.”
Significant events
- “During the year, the Company, formerly known as Biosimilars Newco Limited, changed its name to Biocon Biologics UK Limited and subsequently was converted into a Biocon Biologics UK PLC.”
- “On 22 August 2025, the Company completed a capital reduction in accordance with section 641(1)(a) of the Companies Act 2006 by reducing the share capital by USD 149,997 thousand.”
- “With effect from 1 April 2025, the Company acquired the business and assets of Biocon Biologics International Limited, and with effect from 1 November 2025, the Company acquired the business and assets of Biocon Biologics Global PLC.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ELEMENTAL COMPANY SECRETARY LIMITED | Corporate Secretary | 2025-10-29 | — | — |
| BRADBURY, Daniel Mark | Director | 2026-08-01 | Apr 1961 | American |
| JATAR, Rajendra | Director | 2024-01-24 | Nov 1966 | Irish |
| MAZUMDAR, Claire | Director | 2022-11-29 | May 1989 | Canadian |
| TAMBE, Shreehas Pradeep | Director | 2025-11-03 | Apr 1974 | Indian |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ANNWEILER, Arnd | Director | 2022-07-27 | 2022-11-29 |
| HAGGAR, Nicholas Robert | Director | 2023-11-06 | 2025-01-28 |
| HARMON, Paul | Director | 2022-07-27 | 2022-11-29 |
| PARIKH, Bobby Kanubhai | Director | 2025-03-31 | 2026-07-15 |
| PIOT, Peter | Director | 2022-11-29 | 2025-11-29 |
| WALLS, John Russell Fotheringham | Director | 2022-11-29 | 2025-11-28 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Biocon Biologics International Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2024-03-22 | Active |
| Viatris Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-07-27 | Ceased 2022-11-29 |
Filing timeline
Last 20 of 59 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-11-13 MA Memorandum articles
- 2025-10-29 RESOLUTIONS Resolution
- 2025-10-29 RR01 Reregistration private to public company appoint secretary
- 2025-10-29 CERT5 Certificate re registration private to public limited company
- 2025-10-21 CERTNM Certificate change of name company
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-06 | AA | accounts | Accounts with accounts type full | |
| 2026-08-21 | AP01 | officers | Appoint person director company with name date | |
| 2026-08-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-07-28 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-02 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-28 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-13 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-13 | MA | incorporation | Memorandum articles | |
| 2025-11-06 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-10-29 | RESOLUTIONS | resolution | Resolution | |
| 2025-10-29 | RR01 | change-of-name | Reregistration private to public company appoint secretary | |
| 2025-10-29 | CERT5 | change-of-name | Certificate re registration private to public limited company | |
| 2025-10-29 | MAR | incorporation | Re registration memorandum articles | |
| 2025-10-29 | AUDS | auditors | Auditors statement | |
| 2025-10-29 | AUDR | auditors | Auditors report | |
| 2025-10-29 | BS | accounts | Accounts balance sheet | |
| 2025-10-21 | CERTNM | change-of-name | Certificate change of name company | |
| 2025-08-22 | SH20 | capital | Legacy | |
| 2025-08-22 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2025-08-22 | CAP-SS | insolvency | Legacy |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 17
- Capital events
- 2
- Officers appointed
- 3
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.